Fundraising FoxAmferia
Gothenburg, SE · 2 known investors
Find your way into Amferia
Sign up to see every warm intro you have to Amferia
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Amferia team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
Founders & leadership
AK
Anand Kumar RajasekharanPhD, CEO & Co-founderAnand Kumar Rajasekharan holds a PhD in Materials Science from Chalmers University, Sweden, and is CEO and co-founder of Amferia, which develops antimicrobial hydrogel wound dressings for advanced wound management.
SA
Saba AtefyektaPhD, Sales & Marketing Director & Co-founderSaba Atefyekta holds a PhD and co-founded Amferia, which develops antimicrobial hydrogel wound dressings using peptide technology to treat bacterial infections, including antibiotic-resistant strains, for human and veterinary applications.
MA
Martin AnderssonPhD, R&D Director & Co-founder
Investors · 2
Chalmers Ventures AB✓ confirmed by AmferiaGöteborg · $21.6M
How we know: the company's own site · a partner's Signal profile · funding news · Not right? Tell us
Almi Investlisted by Almi InvestGothenburg · $100K – $1M
How we know: Almi Invest's portfolio page · funding news · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Amferia do?
- Amferia develops antimicrobial hydrogel wound dressings that kill bacteria including antibiotic-resistant strains using peptides bonded to hydrogel, for human and veterinary wound care applications. The company's patented technology creates a new class of medical device approved by the FDA for advanced wound management.
- Who founded Amferia?
- Amferia was founded by Anand Kumar Rajasekharan, Saba Atefyekta, Martin Andersson.
- Who are Amferia's investors?
- Amferia's investors include Chalmers Ventures AB, Almi Invest.
- Where is Amferia headquartered?
- Amferia is headquartered in Gothenburg, SE.